AR022621A1 - Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina - Google Patents
Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotinaInfo
- Publication number
- AR022621A1 AR022621A1 ARP000100678A ARP000100678A AR022621A1 AR 022621 A1 AR022621 A1 AR 022621A1 AR P000100678 A ARP000100678 A AR P000100678A AR P000100678 A ARP000100678 A AR P000100678A AR 022621 A1 AR022621 A1 AR 022621A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- deoxipeganine
- nicotine dependence
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Abstract
La desoxipeganina y sus sales de adicion de ácido farmacéuticamente aceptables pueden utilizarse para el tratamiento de la dependencia de la nicotina.Estas substancias se administran preferentemente de una manera continua y controlada. La forma de administracion farmacéutica posibilita una liberacioncontrolada para, por ejemplo. administracion oral, transdermal o por otra vía parenteral.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19906979A DE19906979B4 (de) | 1999-02-19 | 1999-02-19 | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
Publications (1)
Publication Number | Publication Date |
---|---|
AR022621A1 true AR022621A1 (es) | 2002-09-04 |
Family
ID=7898025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100678A AR022621A1 (es) | 1999-02-19 | 2000-02-17 | Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina |
Country Status (12)
Country | Link |
---|---|
US (1) | US6548510B1 (es) |
EP (1) | EP1150681B1 (es) |
JP (1) | JP4287596B2 (es) |
KR (1) | KR100681631B1 (es) |
AR (1) | AR022621A1 (es) |
AT (1) | ATE314850T1 (es) |
AU (1) | AU2670600A (es) |
DE (2) | DE19906979B4 (es) |
DK (1) | DK1150681T3 (es) |
ES (1) | ES2255977T3 (es) |
PT (1) | PT1150681E (es) |
WO (1) | WO2000048445A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
DE10163667B4 (de) * | 2001-12-21 | 2006-10-26 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
DE10304141B4 (de) | 2003-02-03 | 2006-03-09 | Hf Arzneimittelforschung Gmbh | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
EP1981518B1 (en) * | 2006-07-11 | 2013-05-22 | Adnan Jathlan Al-Rehaily | Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
BR112012024356A2 (pt) | 2010-03-26 | 2016-05-24 | Philip Morris Products Sa | inibição de irritação sensorial durante o consumo de tabaco não fumável |
US10335378B2 (en) | 2013-03-15 | 2019-07-02 | Altria Client Services Llc | Inhibition of central nervous system effects from smoking and sensory effects from smoking |
CN104382964B (zh) * | 2014-10-27 | 2017-07-28 | 上海中医药大学 | 一种由骆驼蓬草制备骆驼蓬草总生物碱提取物和骆驼蓬草总黄酮提取物的方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3760805A (en) | 1971-01-13 | 1973-09-25 | Alza Corp | Osmotic dispenser with collapsible supply container |
US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3742951A (en) | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
SU605614A1 (ru) * | 1971-10-20 | 1978-05-05 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср | Антихолинэстеразное средство |
US3987790A (en) | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4137300A (en) | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
DE3315272C2 (de) | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
DE3629304A1 (de) | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung |
DE3843239C1 (es) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
-
1999
- 1999-02-19 DE DE19906979A patent/DE19906979B4/de not_active Expired - Fee Related
-
2000
- 2000-02-08 WO PCT/EP2000/000975 patent/WO2000048445A2/de active IP Right Grant
- 2000-02-08 AT AT00905035T patent/ATE314850T1/de not_active IP Right Cessation
- 2000-02-08 US US09/889,650 patent/US6548510B1/en not_active Expired - Fee Related
- 2000-02-08 KR KR1020017010491A patent/KR100681631B1/ko not_active IP Right Cessation
- 2000-02-08 PT PT00905035T patent/PT1150681E/pt unknown
- 2000-02-08 AU AU26706/00A patent/AU2670600A/en not_active Abandoned
- 2000-02-08 DE DE50012014T patent/DE50012014D1/de not_active Expired - Fee Related
- 2000-02-08 EP EP00905035A patent/EP1150681B1/de not_active Expired - Lifetime
- 2000-02-08 JP JP2000599251A patent/JP4287596B2/ja not_active Expired - Fee Related
- 2000-02-08 ES ES00905035T patent/ES2255977T3/es not_active Expired - Lifetime
- 2000-02-08 DK DK00905035T patent/DK1150681T3/da active
- 2000-02-17 AR ARP000100678A patent/AR022621A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US6548510B1 (en) | 2003-04-15 |
DE19906979B4 (de) | 2004-07-08 |
DE50012014D1 (de) | 2006-03-30 |
DE19906979A1 (de) | 2000-08-31 |
EP1150681A2 (de) | 2001-11-07 |
EP1150681B1 (de) | 2006-01-04 |
KR100681631B1 (ko) | 2007-02-09 |
PT1150681E (pt) | 2006-05-31 |
KR20010102240A (ko) | 2001-11-15 |
WO2000048445A2 (de) | 2000-08-24 |
DK1150681T3 (da) | 2006-05-22 |
AU2670600A (en) | 2000-09-04 |
ES2255977T3 (es) | 2006-07-16 |
ATE314850T1 (de) | 2006-02-15 |
JP4287596B2 (ja) | 2009-07-01 |
WO2000048445A3 (de) | 2001-04-26 |
JP2002537232A (ja) | 2002-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0107147A (pt) | Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações | |
DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
AR004391A1 (es) | Formulacion de liberacion controlada para farmacos basicos escasamente solubles. | |
GR1000380B (el) | Μορφη δοσολογιας εχουσα μειωμενη πιθανοτητα καταχρησης. | |
UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
AR020001A1 (es) | COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO | |
NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
AR037592A1 (es) | Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno | |
CO5170471A1 (es) | Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio | |
BR0014383A (pt) | Composições de liberação controlada compreendendo nimesulida | |
BR9917012A (pt) | Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral | |
AR022621A1 (es) | Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina | |
CO5640120A2 (es) | Formulacion y metodods para el tratamiento de trombocitemia | |
DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
AR033688A1 (es) | Composicion parenteral reconstituible | |
NO992944L (no) | Virkestoffbµrer for avgivelse av apomorfin i munnhulen | |
AR025938A1 (es) | Nuevas composiciones farmaceuticas. | |
AR018166A1 (es) | Productos utilizables en el tratamiento de tumores, una composicion farmaceutica y el uso de una antraciclina sola o con un inhibidor de topoisomerasa iantineoplasico en la preparacion de medicamentos | |
BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
EE200300371A (et) | Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid | |
UY26371A1 (es) | Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen | |
AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
HUP0000137A2 (hu) | Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény | |
CO4230093A1 (es) | Derivados del indol y sus usos medicos |